Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Definitive Healthcare (DH) Return on Sales (2020 - 2025)

Historic Return on Sales for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to 0.3%.

  • Definitive Healthcare's Return on Sales rose 27000.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.1%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 2.35% for FY2024, which is 11900.0% down from last year.
  • According to the latest figures from Q3 2025, Definitive Healthcare's Return on Sales is 0.3%, which was up 27000.0% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Return on Sales ranged from a high of 0.1% in Q4 2022 and a low of 4.8% during Q2 2024
  • For the 5-year period, Definitive Healthcare's Return on Sales averaged around 0.99%, with its median value being 0.29% (2021).
  • As far as peak fluctuations go, Definitive Healthcare's Return on Sales tumbled by -46100bps in 2024, and later skyrocketed by 46500bps in 2025.
  • Over the past 5 years, Definitive Healthcare's Return on Sales (Quarter) stood at 0.33% in 2021, then skyrocketed by 130bps to 0.1% in 2022, then tumbled by -309bps to 0.2% in 2023, then plummeted by -571bps to 1.36% in 2024, then soared by 78bps to 0.3% in 2025.
  • Its Return on Sales was 0.3% in Q3 2025, compared to 0.15% in Q2 2025 and 2.62% in Q1 2025.